Merck & Company, Inc. News Headlines

MRK 
$59.58
*  
0.60
1.02%
Get MRK Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    MRK Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Cubist Pharmaceuticals: An Extraordinary Arbitrage Opportunity
12/17/2014 11:26:00 AM - Seeking Alpha


The 3 Most Exceptional CEOs of 2014
12/16/2014 7:00:02 PM - Motley Fool


Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog
12/16/2014 6:30:00 PM - Zacks.com


Quick Analysis Of Merck's Acquisition Of Cubist
12/16/2014 1:55:00 PM - Trefis


Pfizer Moving Into Gene Therapy Is A Welcome Move
12/16/2014 1:53:11 PM - Trefis


Assessing Gilead's Reality-Perception Gap
12/16/2014 11:52:00 AM - Seeking Alpha


IUSV, JPM, PFE, MRK: ETF Inflow Alert
12/16/2014 10:55:23 AM - BNK Invest


Graham's Stock Selection Criteria Revisited
12/16/2014 8:52:00 AM - Seeking Alpha


2015 Healthcare Sector Predictions
12/16/2014 6:50:00 AM - Seeking Alpha


Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog
12/16/2014 6:30:00 AM - Investopedia


Backtesting The New Nifty Fifty Using Weighted, Equal-Weight, And Random-Assignment Designs
12/15/2014 3:15:00 PM - Seeking Alpha


Dow Movers: MRK, XOM
12/15/2014 12:59:02 PM - BNK Invest


Superbug Antibiotic Resistance: A Solution May Be Closer
12/15/2014 11:49:00 AM - Seeking Alpha


The New Baupost Biotech Picks
12/15/2014 9:53:00 AM - Seeking Alpha


Merger Arbitrage Mondays - December 15, 2014
12/15/2014 9:41:00 AM - Seeking Alpha


It's Not the Zombie Apocalypse, but Killer Superbugs Could Be on the Way
12/14/2014 7:44:04 AM - Motley Fool


Seeking Alpha's Biotech Weekly: Spark Flies For Pfizer, Sovaldi V. Septa, And More
12/12/2014 3:29:00 PM - Seeking Alpha


Sovaldi Can't Sustain The Current Prices Of Gilead Sciences' Stock: Algorithmic And Fundamental Analysis
12/12/2014 3:27:00 PM - Seeking Alpha


Dividend Growth Investors Focused On Income Earn Higher Total Returns
12/12/2014 12:17:00 PM - Seeking Alpha


Merck Reveals Data from Breast Cancer Study on Keytruda - Analyst Blog
12/11/2014 5:10:00 PM - Zacks.com


Agenus: Herpes Competition And Cancer Checkpoint Prospects
12/11/2014 12:06:00 PM - Seeking Alpha


Gavi gives Ebola vaccine developers an extra incentive to move quickly
12/11/2014 11:58:00 AM - Seeking Alpha


Livestock products lead Zoetis’ 3Q14 revenue growth
12/11/2014 8:00:00 AM - Market Realist


Update: Cubist Pharmaceuticals Is Acquired By Merck, Gains Remain For Investors
12/11/2014 12:31:00 AM - Seeking Alpha


Will The New HPV Vaccine Prove A Shot In The Arm For Merck?
12/10/2014 9:46:00 PM - RTT News